We are live on
!
Find out more
ECP
Elk Creek Partners Portfolio holdings
AUM
$582M
1-Year Est. Return
10.23%
This Fund
S&P 500
This Quarter
Est. Return
+17.02%
1 Year Est. Return
-10.23%
3 Year Est. Return
+16.39%
5 Year Est. Return
+41.52%
10 Year Est. Return
–
AUM
$1.39B
AUM Growth
+$182M
(+15%)
Cap. Flow
+$29.2M
Cap. Flow
% of AUM
2.11%
Top 10 Holdings %
Top 10 Hldgs %
21.32%
Holding
144
New
11
Increased
32
Reduced
89
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
STMP
Stamps.com, Inc.
STMP
|
+$18.7M |
| 2 |
Ligand Pharmaceuticals
LGND
|
+$14.3M |
| 3 |
VCRA
VOCERA COMMUNICATIONS, INC.
VCRA
|
+$12.7M |
| 4 |
QUOT
Quotient Technology Inc
QUOT
|
+$10.1M |
| 5 |
TVTY
Tivity Health, Inc. Common Stock
TVTY
|
+$10M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
+$20.9M |
| 2 |
LOGM
LogMein, Inc.
LOGM
|
+$17.8M |
| 3 |
MaxLinear
MXL
|
+$15M |
| 4 |
TSRO
TESARO, Inc.
TSRO
|
+$7.78M |
| 5 |
Chegg
CHGG
|
+$7.64M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.71% |
| 2 | Industrials | 18.01% |
| 3 | Technology | 15.51% |
| 4 | Communication Services | 12.14% |
| 5 | Consumer Discretionary | 10.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
SBA Communications
SBAC
$19.2B
| $480K | 0.03% |
2,403
-799
| -25% | -$145K |
|
|
ALXN
127
DELISTED
Alexion Pharmaceuticals
ALXN
| $252K | 0.02% |
1,866
-770
| -29% | -$95.7K |
|
128
Centene
CNC
$30.7B
| $245K | 0.02% |
4,622
-1,650
| -26% | -$100K |
|
129
IQVIA
IQV
$38.7B
| $239K | 0.02% |
1,664
-595
| -26% | -$79.3K |
|
|
WP
130
DELISTED
Worldpay, Inc.
WP
| $236K | 0.02% |
2,080
-770
| -27% | -$69.8K |
|
131
Vertex Pharmaceuticals
VRTX
$121B
| $200K | 0.01% |
1,089
-448
| -29% | -$82.7K |
|
132
SiriusXM
SIRI
$9.98B
| $152K | 0.01% |
2,685
-970
| -27% | -$57.8K |
|
133
BioMarin Pharmaceuticals
BMRN
$11.6B
| – | – |
-2,356
| Closed | -$201K |
|
|
134
Chegg
CHGG
$110M
| – | – |
-268,791
| Closed | -$7.64M |
|
135
Camping World
CWH
$639M
| – | – |
-578,279
| Closed | -$6.63M |
|
136
Microchip Technology
MCHP
$40.3B
| – | – |
-5,710
| Closed | -$205K |
|
137
Omnicell
OMCL
$1.61B
| – | – |
-101,431
| Closed | -$6.21M |
|
138
Willis Towers Watson
WTW
$31.2B
| – | – |
-1,441
| Closed | -$219K |
|
139
Yeti Holdings
YETI
$3.71B
| – | – |
-264,774
| Closed | -$3.93M |
|
|
BFX
140
DELISTED
BowFlex Inc.
BFX
| – | – |
-646,506
| Closed | -$7.05M |
|
|
ICPT
141
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| – | – |
-207,657
| Closed | -$20.9M |
|
|
LOGM
142
DELISTED
LogMein, Inc.
LOGM
| – | – |
-217,960
| Closed | -$17.8M |
|
|
ONCE
143
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| – | – |
-184,334
| Closed | -$7.21M |
|
|
TSRO
144
DELISTED
TESARO, Inc.
TSRO
| – | – |
-104,836
| Closed | -$7.78M |
|
Similar funds
BAC
AVC
OWD
PP
WWM
JA
PL
EA
Elk Creek Partners's Q1 2019 Portfolio in Review
As of Q1 2019, Elk Creek Partners held 144 positions worth $1.39B, up 15% from $1.21B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Elk Creek Partners's Q1 2019 filing shows 11 new, 32 increased, 89 reduced and 12 closed positions. Its largest new stake was Stamps.com, Inc.: 132,819 shares worth $10.8M. The largest sale was Intercept Pharmaceuticals, Inc., an estimated $20.9M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Industrials and Technology.
- Elk Creek Partners's largest Q1 2019 buy was Stamps.com, Inc.: 132,819 shares worth $10.8M.
- Elk Creek Partners added most to Ligand Pharmaceuticals in Q1 2019, an estimated $14.3M increase.
- Elk Creek Partners's biggest Q1 2019 reduction was MaxLinear, cutting an estimated $15M.
- Elk Creek Partners fully exited Intercept Pharmaceuticals, Inc. in Q1 2019, selling an estimated $20.9M.
- Elk Creek Partners's ten largest holdings make up 21% of its $1.39B portfolio in Q1 2019.
- Elk Creek Partners opened 11 new positions and closed 12 in Q1 2019.
- Elk Creek Partners's portfolio value rose 15% quarter-over-quarter to $1.39B.
Based on Elk Creek Partners's 13F filing for Q1 2019, filed 10 May 2019.